This subject explores pathophysiological processes contributing to disease. This subject focuses on pathophysiological processes associated with musculoskeletal, cardiovascular and respiratory dysfunction. Relevant pharmacology is integrated throughout.
HD/FL
One session
School of Biomedical Sciences
BMS192 or ( BMS130 and MCR101 )
BMS101, BMS102, BMS121, BMS122, BMS221, BMS222, BMS231, BMS232
PATHOPHYSIOOGICAL AND PHARMACOLOGICAL FOUNDATIONS
* Cell injury, adaptation and death
* Pharmacokinetics and pharmacodynamics
GENERAL PATHOPHYSIOLOGY AND ASSOCIATED PHARMACOLOGY
* Fluid, electrolyte and acid-base imbalances
* Pain and analgesic agents
* Inflammation and anti-inflammatory agents
* Infectious disease and antimicrobial agents
* Neoplastic disorders and antineoplastic agents
SYSTEMATIC PATHOPHYSIOLOGY AND ASSOCIATED PHARMACOLOGY
* Cardiovascular dysfunction (coagulopathy, hypertension, atherosclerosis, dysrhythmias, pump failure) and associated pharmacology
* Respiratory dysfunction (asthma, chronic airways limitation, hypoventilation, pulmonary hypertension) and associated pharmacology
* Musculoskeletal dysfunction (arthritis, osteoporosis, metabolic disorders, muscular dystrophy) and associated pharmacology
For further information about courses and subjects outlined in the CSU handbook please contact:
The information contained in the CSU Handbook was accurate at the date of publication: May 2019. The University reserves the right to vary the information at any time without notice.